on007864
Neuroepo multisession Phase II and III
EEG
A randomized, placebo-controlled clinical trial investigating the neuroprotective and neuromodulatory effects of intranasal NeuroEPO (erythropoietin) in Parkinson's disease patients. The dataset comprises multisession EEG recordings and clinical assessments collected at baseline and 9-month post-intervention timepoints, with the goal of examining whether NeuroEPO-related cognitive and motor effects are mediated by changes in EEG source activity. This Phase II/III study provides evidence for functional brain reorganization mechanisms underlying EPO treatment in neurodegenerative disease.
- Size
- 36 B
- Updated
- Jun 19, 2026